Lavandulol, (+/-)-

Details

Top
Internal ID f2c866d5-e06f-4d57-90a0-25ced0376fd9
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Monoterpenoids > Acyclic monoterpenoids
IUPAC Name 5-methyl-2-prop-1-en-2-ylhex-4-en-1-ol
SMILES (Canonical) CC(=CCC(CO)C(=C)C)C
SMILES (Isomeric) CC(=CCC(CO)C(=C)C)C
InChI InChI=1S/C10H18O/c1-8(2)5-6-10(7-11)9(3)4/h5,10-11H,3,6-7H2,1-2,4H3
InChI Key CZVXBFUKBZRMKR-UHFFFAOYSA-N
Popularity 158 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H18O
Molecular Weight 154.25 g/mol
Exact Mass 154.135765193 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 3.00
Atomic LogP (AlogP) 2.53
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 4

Synonyms

Top
(+/-)-Lavandulol
5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-ol
4-Hexen-1-ol, 5-methyl-2-(1-methylethenyl)-
1845-51-8
Lavandulol, (+/-)-
5-methyl-2-prop-1-en-2-ylhex-4-en-1-ol
UNII-1YPC7F65XU
1YPC7F65XU
EINECS 261-264-2
2-Isopropenyl-5-methylhex-4-en-1-ol
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Lavandulol, (+/-)-

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9912 99.12%
Caco-2 + 0.5560 55.60%
Blood Brain Barrier + 0.9750 97.50%
Human oral bioavailability - 0.6000 60.00%
Subcellular localzation Lysosomes 0.5671 56.71%
OATP2B1 inhibitior - 0.8551 85.51%
OATP1B1 inhibitior + 0.9429 94.29%
OATP1B3 inhibitior + 0.9489 94.89%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior - 0.8993 89.93%
P-glycoprotein inhibitior - 0.9669 96.69%
P-glycoprotein substrate - 0.9616 96.16%
CYP3A4 substrate - 0.6803 68.03%
CYP2C9 substrate - 0.6591 65.91%
CYP2D6 substrate - 0.7543 75.43%
CYP3A4 inhibition - 0.8412 84.12%
CYP2C9 inhibition - 0.8791 87.91%
CYP2C19 inhibition - 0.8368 83.68%
CYP2D6 inhibition - 0.9170 91.70%
CYP1A2 inhibition - 0.8558 85.58%
CYP2C8 inhibition - 0.9808 98.08%
CYP inhibitory promiscuity - 0.8375 83.75%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.5200 52.00%
Carcinogenicity (trinary) Non-required 0.6866 68.66%
Eye corrosion + 0.7717 77.17%
Eye irritation + 0.9858 98.58%
Skin irritation + 0.7643 76.43%
Skin corrosion + 0.7506 75.06%
Ames mutagenesis - 0.8183 81.83%
Human Ether-a-go-go-Related Gene inhibition - 0.4592 45.92%
Micronuclear - 0.9900 99.00%
Hepatotoxicity + 0.5713 57.13%
skin sensitisation + 0.5706 57.06%
Respiratory toxicity - 0.8778 87.78%
Reproductive toxicity - 0.9608 96.08%
Mitochondrial toxicity - 0.7250 72.50%
Nephrotoxicity + 0.5305 53.05%
Acute Oral Toxicity (c) III 0.7462 74.62%
Estrogen receptor binding - 0.9397 93.97%
Androgen receptor binding - 0.9130 91.30%
Thyroid receptor binding - 0.9051 90.51%
Glucocorticoid receptor binding - 0.9304 93.04%
Aromatase binding - 0.8519 85.19%
PPAR gamma - 0.8957 89.57%
Honey bee toxicity - 0.8601 86.01%
Biodegradation + 0.6500 65.00%
Crustacea aquatic toxicity - 0.9200 92.00%
Fish aquatic toxicity + 0.8373 83.73%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 92.45% 83.82%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 82.39% 94.45%
CHEMBL1977 P11473 Vitamin D receptor 81.45% 99.43%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 81.43% 96.09%
CHEMBL226 P30542 Adenosine A1 receptor 80.93% 95.93%

Cross-Links

Top
PubChem 94060
NPASS NPC112734
LOTUS LTS0111607
wikiData Q616128